To ascertain the potential cellular targets of CCL2 in PMF, we found that PMF hematopoietic progenitors selectively overexpress CCR2 as compared not only to HD but also to other MPN subtypes, such as ET and PV. The gene discussed is CCL2; the disease is myeloproliferative disorder.